Literature DB >> 1783768

Sepsis syndrome. New insights into its pathogenesis and treatment.

R C Bone1.   

Abstract

Recent insights into the pathogenesis of sepsis and its sequelae have opened up new approaches to treatment. For maximum effectiveness, however, treatment must be given as early as possible in the course of illness--but only to patients who are at high risk of developing shock. The definition of sepsis syndrome outlined in this article provides a method by which to identify such patients before the onset of shock.

Entities:  

Mesh:

Year:  1991        PMID: 1783768

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  6 in total

1.  Clostridium difficile infection as a cause of severe sepsis.

Authors:  S E Lowenkron; J Waxner; P Khullar; J S Ilowite; M S Niederman; A M Fein
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

2.  Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice.

Authors:  F Alves-Rosa; M Vulcano; M Beigier-Bompadre; G Fernández; M Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle.

Authors:  G Tiao; S Hobler; J J Wang; T A Meyer; F A Luchette; J E Fischer; P O Hasselgren
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice.

Authors:  Donn Spight; Bruce Trapnell; Bin Zhao; Pierre Berclaz; Thomas P Shanley
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

5.  Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.

Authors:  C R Amura; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 6.  Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease.

Authors:  Sebastian Steven; Thomas Münzel; Andreas Daiber
Journal:  Int J Mol Sci       Date:  2015-08-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.